03 May SoCal TMS Medical Director is lead author on two more scholarly publications on effectiveness of TMS on Anxious Depression & Major Depressive Disorder
Dr. Todd Hutton, Medical Director of SoCal TMS, has long been recognized as a leader and noted expert in the field of TMS. Dr Hutton was just published again, twice as lead author of two more scholarly articles.
The most recent paper “The Anxiolytic and Antidepressant Effects of Transcranial Magnetic Stimulation in Patients With Anxious Depression” in the Journal of Clinical Psychiatry, shows that TMS has a clinically meaningful effect on patients who have both depression and anxiety. “Routine TMS delivered in diverse clinical settings results in marked anxiolytic and antidepressant effects in patients with anxious depression. The extent of improvement in anxiety and depression symptoms strongly covaries“
The other paper, “Dosing Transcranial Magnetic Stimulation: Efficacy in Major Depressive Disorder as a function of number of treatment sessions“, shows that TMS is more effective as the number of treatment sessions increases. “Data from this real-world, large database cohort, demonstrates a strong correlation between number of sessions in the TMS acute course and favorable MDD clinical outcomes. This increased benefit with increased treatment exposure also applies to individuals with incomplete benefit after 30 and 36 sessions. Extended treatment courses are associated with improved outcomes.”
You can click on this link to see a list of all of Dr Hutton’s publications.